EMA Names First Four Products To Enter Priority Medicines PRIME Scheme
This article was originally published in SRA
Executive Summary
The European Medicines Agency has announced the names of the first four products to be accepted for assessment under the agency's PRIME (priority medicines) scheme, which was launched on March 71.